Company Overview of Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule that completed Phase IIa clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which is in pre-clinical trials for the treatment of type 2 diabetes. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.
Hi-Tech Park 2/4
PO Box 39098
Founded in 2002
Key Executives for Oramed Pharmaceuticals Inc.
Chief Executive Officer, President and Executive Director
Total Annual Compensation: $381.3K
Chief Financial Officer, Treasurer and Secretary
Total Annual Compensation: $193.8K
Chief Operating Officer and Vice President of Business Development
Total Annual Compensation: $199.2K
Chief Scientific Officer and Director
Total Annual Compensation: $271.3K
Compensation as of Fiscal Year 2014.
Oramed Pharmaceuticals Inc. Key Developments
Oramed Pharmaceuticals Inc. Submits Protocol to U.S. FDA for its Phase IIb Oral Insulin Study
May 26 15
Oramed Pharmaceuticals Inc. announced that it has submitted the study protocol for the company's Phase IIb trial of ORMD-0801, its oral insulin capsule, to the U.S. Food and Drug Administration (FDA). The submission was made under the company's existing Investigational New Drug (IND) application. The Phase IIb study of ORMD-0801 for type 2 diabetics is designed to generate ample data for both efficacy and safety endpoints. The double-blind, randomized study will recruit approximately 180 patients and has a 28-day treatment period. The study has already received Institutional Review Board (IRB) approval and patient enrollment is expected to start in the short term.
Oramed Pharmaceuticals Inc. Presents at Oppenheimer16th Annual Israeli Conference, May-10-2015 01:45 PM
May 5 15
Oramed Pharmaceuticals Inc. Presents at Oppenheimer16th Annual Israeli Conference, May-10-2015 01:45 PM. Venue: David Intercontinental Hotel, Tel-Aviv, Israel. Speakers: Nadav Kidron, Chief Executive Officer, President and Executive Director.
Oramed Pharmaceuticals Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 12:30 PM
Feb 13 15
Oramed Pharmaceuticals Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 12:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Michael Berelowitz, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 3, 2014
Most Searched Private Companies
Sponsored Financial Commentaries